Testing effectiveness (Phase 2)Not Yet RecruitingNCT07516210
What this trial is testing
Adaptive Radiotherapy for Safe Hypofractionation
Who this might be right for
CancerEndometrial CancerProstate Cancer+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 264